IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
INNOSPEC INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$97.99+1.18 (+1.22%)
Close on Oct 19, 2026
- Market cap
- $2.42B
- P/E (TTM)
- 21.0
- Dividend yield
- 1.75%
Share price
+$23.91 (+32.28%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
INNOSPEC INC. grew revenue 2.9% to $1.84B over the twelve months to Jun 30, 2026. Operating income fell 21.2% to $128.90M, moving the operating margin from 9.1% to 7.0%.
Revenue
$1.84B
+2.9% vs. a year earlier
Operating income
$128.90M
-21.2% vs. a year earlier
EPS, diluted
$4.67
+228.9% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.42B
- P/E ratio
- 21.0
- Price to sales
- 1.31
- Price to book
- 1.80
- Dividend yield
- 1.75%
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.84B
- EPS, diluted
- $4.67
- Book value per share
- $54.37
- Diluted shares
- 25M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$1.84B+2.9% YoY
Gross profit
$505.90M-0.5% YoY
Operating income
$128.90M-21.2% YoY
Net income
–
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months